Mildred Caro Ruiz, M.D.
NPI 1518053438ActiveIndividual· Internal Medicine, Pulmonary Disease· Aguada, PR
Internal Medicine, Pulmonary Disease (M.D.) in Aguada, Puerto Rico, trained at Ponce School of Medicine (class of 1984). Their prescriptions cost Medicare Part D more than their services did: $1,908,584 for 6,779 claims, against $3,640 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 5 companies reporting payments in 2025, $575.43 in all, mostly food and beverage.
Overview
| NPI | 1518053438 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Oct 5, 2006 |
| Last updated in NPPES | Jul 8, 2007 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Pulmonary Disease Primary | 207RP1001X | 14026 | PR |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Pulmonary Disease (PR) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 26 |
|---|---|
| Services billed | 62 across 4 procedure codes |
| Paid by Medicare | $3,640 |
Part D prescriptions in 2024
| Prescriptions (claims) | 6,779 · 6,989 30-day fills |
|---|---|
| Patients | 728 |
| Total drug cost | $1,908,584 |
Education and affiliations
| Medical school | Ponce School of Medicine |
|---|---|
| Graduation year | 1984 |
| Medicare specialty | Pulmonary Disease |
| Secondary specialties | Critical Care (Intensivists), Internal Medicine |
Industry payments (Open Payments)
- 2025$575.43 · 18 payments from 5 companies
- 2024$322.59 · 18 payments from 5 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $405.60 | 13 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $81.96 | 2 |
| Merck Sharp & Dohme LLC | $39.32 | 1 |
| Viatris Specialty LLC | $28.57 | 1 |
| United Therapeutics Corporation | $19.98 | 1 |
What the 2025 payments were for
- Food and Beverage$575.43 · 18 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records